• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道子宫切除术治疗盆腔器官脱垂患者隐匿性恶性肿瘤的发生率及相关因素。

The incidence and risk factors of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse.

机构信息

Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Institute of Women's Life Medical Science, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

出版信息

Int Urogynecol J. 2023 Nov;34(11):2719-2724. doi: 10.1007/s00192-023-05576-4. Epub 2023 Jul 4.

DOI:10.1007/s00192-023-05576-4
PMID:37401960
Abstract

INTRODUCTION AND HYPOTHESIS

The aim of this study was to assess the incidence and risk factors for premalignant and malignant pathology in patients receiving vaginal hysterectomy (VH) and pelvic floor repair (PFR) for pelvic organ prolapse (POP).

METHODS

We performed a retrospective cohort study of pathological results after VH and PFR of 569 women at our institution from January 2011 through December 2020. Age, body mass index (BMI), POP-Q stage, and preoperative ultrasound results were evaluated as risk factors for occult malignancy.

RESULTS

Six of the 569 patients (1.1%) had unanticipated premalignant uterine pathology and 2 (0.4%) had unanticipated malignant uterine pathology (endometrial cancer). There was no significant difference in the incidence of premalignant or malignant uterine pathology according to age, BMI, and POP-Q stage. However, if endometrial pathology is confirmed on preoperative ultrasonography, the probability of confirming malignant pathology increases (OR 4.63; 95% CI 1.84-51.4; p=0.016).

CONCLUSION

The incidence of occult malignancy during VH for POP was significantly lower than that found in hysterectomy owing to benign disease. In the case of POP patients, for whom uterine-conserving surgery is not absolutely contraindicated, it can be performed. However, if endometrial pathology is confirmed by preoperative ultrasonography, uterine-conserving surgery is not recommended.

摘要

引言与假设

本研究旨在评估因盆腔器官脱垂(POP)接受阴道子宫切除术(VH)和盆底修复(PFR)的患者中,发生癌前病变和恶性病变的发生率及相关危险因素。

方法

我们对 2011 年 1 月至 2020 年 12 月期间我院 569 例行 VH 和 PFR 的患者的病理结果进行了回顾性队列研究。评估了年龄、体重指数(BMI)、POP-Q 分期和术前超声结果等因素,作为隐匿性恶性肿瘤的危险因素。

结果

569 例患者中有 6 例(1.1%)出现意外的癌前子宫病变,2 例(0.4%)出现意外的恶性子宫病变(子宫内膜癌)。隐匿性恶性子宫病变的发生率与年龄、BMI 和 POP-Q 分期无显著差异。然而,如果术前超声检查证实存在子宫内膜病变,则恶性病变的概率增加(OR 4.63;95%CI 1.84-51.4;p=0.016)。

结论

POP 行 VH 时隐匿性恶性肿瘤的发生率明显低于因良性疾病行子宫切除术的发生率。对于那些并非绝对禁忌行保留子宫手术的 POP 患者,可以进行该手术。然而,如果术前超声检查证实存在子宫内膜病变,则不建议行保留子宫手术。

相似文献

1
The incidence and risk factors of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse.阴道子宫切除术治疗盆腔器官脱垂患者隐匿性恶性肿瘤的发生率及相关因素。
Int Urogynecol J. 2023 Nov;34(11):2719-2724. doi: 10.1007/s00192-023-05576-4. Epub 2023 Jul 4.
2
Abnormal Pathology Following Vaginal Hysterectomy for Pelvic Organ Prolapse Repair.阴道子宫切除术治疗盆腔器官脱垂修复术后的异常病理
J Womens Health (Larchmt). 2024 Oct;33(10):1423-1427. doi: 10.1089/jwh.2023.1019. Epub 2024 May 3.
3
Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative Workup.尽管术前检查无异常,但阴道子宫切除术中意外发现子宫存在重大病理结果。
Isr Med Assoc J. 2017 Oct;19(10):631-634.
4
Pelvic organ prolapse after laparoscopic hysterectomy compared with vaginal hysterectomy: the POP-UP study.腹腔镜子宫切除术与阴道子宫切除术治疗盆腔器官脱垂的比较:POP-UP 研究。
Int Urogynecol J. 2021 Apr;32(4):841-850. doi: 10.1007/s00192-020-04591-z. Epub 2020 Nov 10.
5
Pelvic organ prolapse surgery following hysterectomy with benign indication: a national cohort study in Taiwan.良性指征子宫切除术后盆腔器官脱垂手术:台湾一项全国队列研究
Int Urogynecol J. 2018 Nov;29(11):1669-1674. doi: 10.1007/s00192-018-3689-0. Epub 2018 Jun 19.
6
Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction.术前子宫内膜评估在因盆底功能障碍接受子宫切除术的无症状女性中的应用价值。
Int Urogynecol J. 2012 Jul;23(7):913-7. doi: 10.1007/s00192-012-1694-2. Epub 2012 Mar 8.
7
Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.阴道子宫切除术治疗盆腔器官脱垂患者的癌前妇科病变和妇科癌症的患病率。
Ann Med. 2023;55(2):2273428. doi: 10.1080/07853890.2023.2273428. Epub 2023 Oct 26.
8
Comparison of two natural tissue repair-based surgical techniques; sacrospinous fixation and uterosacral ligament suspension for pelvic organ prolapse treatment.两种基于自然组织修复的手术技术比较;骶棘韧带固定术和子宫骶骨韧带悬吊术治疗盆腔器官脱垂。
J Gynecol Obstet Hum Reprod. 2021 Apr;50(4):101905. doi: 10.1016/j.jogoh.2020.101905. Epub 2020 Sep 8.
9
Incidence of Occult Uterine Pathology in Women Undergoing Hysterectomy With Pelvic Organ Prolapse Repair.接受子宫脱垂修复术的子宫切除术中隐匿性子宫病变的发生率。
Female Pelvic Med Reconstr Surg. 2016 Sep-Oct;22(5):332-5. doi: 10.1097/SPV.0000000000000283.
10
Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.不同途径的盆腔器官脱垂修复术后静脉血栓栓塞事件的发生率和危险因素。
Am J Obstet Gynecol. 2020 Aug;223(2):268.e1-268.e26. doi: 10.1016/j.ajog.2020.05.020. Epub 2020 May 13.

引用本文的文献

1
Thermodynamic Work of High-Grade Uterine Prolapse Patients Undergoing Transvaginal Mesh Repair with Total Hysterectomy.行经阴道网片修补术加全子宫切除术的重度子宫脱垂患者的热力学功
Bioengineering (Basel). 2024 Aug 28;11(9):875. doi: 10.3390/bioengineering11090875.

本文引用的文献

1
Management of Pelvic Organ Prolapse (POP) and Rectal Prolapse.盆腔器官脱垂(POP)和直肠脱垂的管理
J Anus Rectum Colon. 2022 Apr 27;6(2):83-91. doi: 10.23922/jarc.2020-007. eCollection 2022.
2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.韩国癌症统计数据:2019 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2022 Apr;54(2):330-344. doi: 10.4143/crt.2022.128. Epub 2022 Mar 16.
3
Appropriateness of hysterectomies at the time of surgical removal of presumed benign adnexal masses.
在手术切除疑似良性附件肿块时行子宫切除术的适宜性。
Int J Gynaecol Obstet. 2022 Oct;159(1):122-128. doi: 10.1002/ijgo.14110. Epub 2022 Feb 9.
4
Evaluation and Management of Pelvic Organ Prolapse.盆腔器官脱垂的评估与管理。
Mayo Clin Proc. 2021 Dec;96(12):3122-3129. doi: 10.1016/j.mayocp.2021.09.005.
5
Complications and objective outcomes of uterine preserving surgeries for the repair of pelvic organ prolapse versus procedures removing the Uterus, a systematic review.保留子宫的盆腔器官脱垂修复手术与切除子宫手术的并发症和客观结局:系统评价。
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:90-98. doi: 10.1016/j.ejogrb.2021.10.020. Epub 2021 Oct 22.
6
Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse.盆腔器官脱垂的流行病学、诊断和病理生理学的叙述性综述。
Int Braz J Urol. 2020 Jan-Feb;46(1):5-14. doi: 10.1590/S1677-5538.IBJU.2018.0581.
7
Comparison of vaginal hysterectomy and laparoscopic hysterectomy: a systematic review and meta-analysis.阴道子宫切除术与腹腔镜子宫切除术的比较:系统评价和荟萃分析。
BMC Womens Health. 2019 Jun 24;19(1):83. doi: 10.1186/s12905-019-0784-4.
8
2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea.2018年韩国肥胖研究学会韩国肥胖管理指南
J Obes Metab Syndr. 2019 Mar;28(1):40-45. doi: 10.7570/jomes.2019.28.1.40. Epub 2019 Mar 30.
9
Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?脱垂手术与阴道子宫托治疗症状性盆腔器官脱垂妇女:哪些因素影响治疗选择?
Arch Gynecol Obstet. 2019 Mar;299(3):773-777. doi: 10.1007/s00404-019-05046-7. Epub 2019 Jan 17.
10
Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.意外的恶性子宫病理学:在大型单中心假定良性子宫疾病子宫切除术系列中发病率、特征和结局。
Gynecol Oncol. 2019 Apr;153(1):49-54. doi: 10.1016/j.ygyno.2018.12.026. Epub 2019 Jan 8.